Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cervix Uteri | 5 | 2008 | 21 | 1.190 |
Why?
|
Spinal Cord | 14 | 2006 | 113 | 0.810 |
Why?
|
Morphine | 5 | 2008 | 40 | 0.740 |
Why?
|
Pain | 5 | 2010 | 247 | 0.710 |
Why?
|
Rats, Sprague-Dawley | 17 | 2015 | 624 | 0.670 |
Why?
|
Neurons, Afferent | 3 | 2008 | 33 | 0.620 |
Why?
|
Analgesics, Opioid | 6 | 2015 | 194 | 0.620 |
Why?
|
TRPV Cation Channels | 2 | 2007 | 17 | 0.590 |
Why?
|
Estrogens | 3 | 2007 | 170 | 0.590 |
Why?
|
Rats | 17 | 2015 | 1425 | 0.580 |
Why?
|
Clonidine | 10 | 2004 | 57 | 0.540 |
Why?
|
Injections, Spinal | 16 | 2015 | 108 | 0.480 |
Why?
|
Adrenergic alpha-Agonists | 7 | 2004 | 38 | 0.450 |
Why?
|
Animals | 33 | 2015 | 6402 | 0.430 |
Why?
|
Physical Stimulation | 7 | 2015 | 73 | 0.400 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2015 | 39 | 0.380 |
Why?
|
Hyperalgesia | 3 | 2015 | 74 | 0.370 |
Why?
|
Ganglia, Spinal | 2 | 2008 | 59 | 0.350 |
Why?
|
Pain Measurement | 7 | 2015 | 328 | 0.350 |
Why?
|
Ketorolac | 4 | 2015 | 24 | 0.340 |
Why?
|
Labor, Obstetric | 2 | 2008 | 31 | 0.330 |
Why?
|
Pain, Postoperative | 3 | 2006 | 167 | 0.330 |
Why?
|
Labor Pain | 1 | 2008 | 8 | 0.330 |
Why?
|
Uterus | 3 | 2004 | 74 | 0.320 |
Why?
|
Models, Animal | 1 | 2008 | 148 | 0.320 |
Why?
|
Behavior, Animal | 2 | 2008 | 149 | 0.320 |
Why?
|
Dilatation, Pathologic | 1 | 2007 | 19 | 0.310 |
Why?
|
Analgesics | 3 | 2004 | 101 | 0.310 |
Why?
|
Female | 32 | 2019 | 17679 | 0.300 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2006 | 8 | 0.290 |
Why?
|
Receptors, Purinergic P2 | 1 | 2006 | 8 | 0.290 |
Why?
|
Somatostatin | 1 | 2006 | 9 | 0.290 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2006 | 41 | 0.280 |
Why?
|
Hypothermia, Induced | 1 | 2005 | 16 | 0.270 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2005 | 7 | 0.270 |
Why?
|
Interleukin-1 | 1 | 2005 | 35 | 0.270 |
Why?
|
Mechanotransduction, Cellular | 1 | 2005 | 9 | 0.270 |
Why?
|
Neostigmine | 6 | 1996 | 16 | 0.260 |
Why?
|
Disease Models, Animal | 2 | 2015 | 915 | 0.250 |
Why?
|
Neurotransmitter Uptake Inhibitors | 1 | 2004 | 3 | 0.250 |
Why?
|
Cyclopropanes | 1 | 2004 | 17 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 203 | 0.240 |
Why?
|
Genes, fos | 1 | 2003 | 3 | 0.240 |
Why?
|
Piperidines | 3 | 2015 | 84 | 0.240 |
Why?
|
Posterior Horn Cells | 1 | 2003 | 11 | 0.240 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 74 | 0.230 |
Why?
|
Hemodynamics | 7 | 2004 | 158 | 0.220 |
Why?
|
Acetylcholine | 7 | 2001 | 38 | 0.200 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2000 | 10 | 0.200 |
Why?
|
Analgesia, Epidural | 3 | 1996 | 48 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2015 | 436 | 0.190 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 467 | 0.190 |
Why?
|
Cerebral Hemorrhage | 1 | 2000 | 56 | 0.190 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 14 | 0.190 |
Why?
|
Respiration, Artificial | 1 | 2020 | 93 | 0.180 |
Why?
|
Anesthesia | 2 | 2019 | 64 | 0.180 |
Why?
|
Hindlimb | 3 | 2008 | 56 | 0.180 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 70 | 0.180 |
Why?
|
Coronavirus Infections | 1 | 2020 | 66 | 0.170 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 71 | 0.170 |
Why?
|
Cytokine-Induced Killer Cells | 1 | 2018 | 1 | 0.170 |
Why?
|
Immunotherapy, Adoptive | 1 | 2018 | 10 | 0.170 |
Why?
|
Clinical Competence | 2 | 2019 | 296 | 0.170 |
Why?
|
Hot Temperature | 4 | 2015 | 62 | 0.170 |
Why?
|
Nitric Oxide | 5 | 1997 | 109 | 0.170 |
Why?
|
Immunohistochemistry | 4 | 2015 | 515 | 0.160 |
Why?
|
Alfentanil | 1 | 1997 | 1 | 0.160 |
Why?
|
Amitriptyline | 1 | 1997 | 6 | 0.160 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1997 | 5 | 0.160 |
Why?
|
Sheep | 15 | 1999 | 218 | 0.150 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 152 | 0.150 |
Why?
|
Skin | 2 | 2018 | 200 | 0.150 |
Why?
|
Afferent Pathways | 2 | 2008 | 13 | 0.150 |
Why?
|
Ephedrine | 2 | 1996 | 3 | 0.150 |
Why?
|
Cholinesterase Inhibitors | 1 | 1996 | 28 | 0.140 |
Why?
|
Norepinephrine | 4 | 1997 | 54 | 0.140 |
Why?
|
Certification | 1 | 2016 | 22 | 0.140 |
Why?
|
Capsaicin | 3 | 2010 | 20 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 317 | 0.130 |
Why?
|
Adult | 10 | 2018 | 8243 | 0.130 |
Why?
|
Cell Transdifferentiation | 1 | 2015 | 6 | 0.130 |
Why?
|
Umbilical Cord | 1 | 2015 | 8 | 0.130 |
Why?
|
Educational Measurement | 1 | 2016 | 106 | 0.130 |
Why?
|
Anesthesiology | 1 | 2016 | 49 | 0.130 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2015 | 11 | 0.130 |
Why?
|
Oxytocin | 1 | 2015 | 21 | 0.130 |
Why?
|
China | 3 | 2020 | 42 | 0.130 |
Why?
|
Male | 16 | 2019 | 16967 | 0.120 |
Why?
|
Pregnancy | 6 | 2008 | 799 | 0.120 |
Why?
|
Stroke | 1 | 2019 | 443 | 0.120 |
Why?
|
Nociceptors | 2 | 2012 | 40 | 0.120 |
Why?
|
Catheterization | 2 | 2004 | 55 | 0.120 |
Why?
|
Wound Healing | 1 | 2015 | 180 | 0.120 |
Why?
|
Metaraminol | 2 | 1996 | 2 | 0.120 |
Why?
|
Pregnancy, Animal | 2 | 2008 | 18 | 0.120 |
Why?
|
Naloxone | 2 | 2012 | 21 | 0.120 |
Why?
|
Psoriasis | 1 | 2018 | 334 | 0.110 |
Why?
|
Endothelium, Vascular | 3 | 1996 | 149 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 161 | 0.110 |
Why?
|
Humans | 16 | 2020 | 28304 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 2 | 1994 | 71 | 0.110 |
Why?
|
Opioid Peptides | 1 | 2012 | 7 | 0.110 |
Why?
|
Uterine Contraction | 1 | 1992 | 7 | 0.110 |
Why?
|
Wounds and Injuries | 1 | 2015 | 238 | 0.110 |
Why?
|
Action Potentials | 3 | 2008 | 115 | 0.100 |
Why?
|
Time Factors | 3 | 2019 | 1874 | 0.100 |
Why?
|
Nitric Oxide Synthase | 4 | 1996 | 28 | 0.090 |
Why?
|
Tissue Engineering | 1 | 2015 | 607 | 0.090 |
Why?
|
Nesting Behavior | 1 | 2008 | 3 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2008 | 26 | 0.080 |
Why?
|
Injections, Intravenous | 3 | 2004 | 56 | 0.080 |
Why?
|
Stimulation, Chemical | 3 | 2015 | 10 | 0.080 |
Why?
|
Analgesia, Obstetrical | 1 | 2008 | 47 | 0.080 |
Why?
|
Drug Interactions | 2 | 1997 | 55 | 0.080 |
Why?
|
Imidazoles | 5 | 1999 | 119 | 0.070 |
Why?
|
Neurons | 1 | 2008 | 191 | 0.070 |
Why?
|
Administration, Cutaneous | 1 | 2006 | 106 | 0.070 |
Why?
|
Cyclooxygenase 1 | 1 | 2006 | 22 | 0.070 |
Why?
|
Taurocholic Acid | 1 | 2005 | 1 | 0.070 |
Why?
|
Amylases | 1 | 2005 | 2 | 0.070 |
Why?
|
Cholagogues and Choleretics | 1 | 2005 | 4 | 0.070 |
Why?
|
Analgesia | 2 | 1996 | 30 | 0.070 |
Why?
|
Edema | 1 | 2005 | 30 | 0.070 |
Why?
|
Lipase | 1 | 2005 | 29 | 0.070 |
Why?
|
Age Factors | 3 | 2019 | 1058 | 0.060 |
Why?
|
Organ Size | 1 | 2005 | 204 | 0.060 |
Why?
|
Pancreas | 1 | 2005 | 80 | 0.060 |
Why?
|
Acute Disease | 1 | 2005 | 234 | 0.060 |
Why?
|
Sciatic Nerve | 1 | 2004 | 35 | 0.060 |
Why?
|
Rectum | 1 | 2004 | 17 | 0.060 |
Why?
|
Electromyography | 1 | 2004 | 55 | 0.060 |
Why?
|
Nerve Block | 1 | 2004 | 48 | 0.060 |
Why?
|
Colon | 1 | 2004 | 56 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 68 | 0.060 |
Why?
|
Succinate Dehydrogenase | 1 | 2003 | 3 | 0.060 |
Why?
|
Ovariectomy | 1 | 2004 | 153 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 31 | 0.060 |
Why?
|
Dioxanes | 5 | 1996 | 6 | 0.060 |
Why?
|
Idazoxan | 5 | 1996 | 9 | 0.060 |
Why?
|
Adrenergic alpha-Antagonists | 5 | 1996 | 26 | 0.060 |
Why?
|
Survival Rate | 1 | 2005 | 775 | 0.060 |
Why?
|
Middle Aged | 4 | 2019 | 10678 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2005 | 846 | 0.050 |
Why?
|
Young Adult | 3 | 2015 | 2321 | 0.050 |
Why?
|
Cholinergic Fibers | 1 | 2001 | 5 | 0.050 |
Why?
|
Diencephalon | 1 | 2000 | 1 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-2 | 3 | 1996 | 25 | 0.050 |
Why?
|
Seizures | 1 | 2000 | 47 | 0.050 |
Why?
|
Regional Blood Flow | 4 | 2004 | 80 | 0.050 |
Why?
|
Hospitals | 1 | 2020 | 72 | 0.050 |
Why?
|
Indans | 1 | 1999 | 21 | 0.050 |
Why?
|
Neurotransmitter Agents | 2 | 1997 | 20 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2019 | 60 | 0.040 |
Why?
|
Patient Selection | 1 | 2020 | 249 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 75 | 0.040 |
Why?
|
Receptors, Muscarinic | 2 | 1995 | 9 | 0.040 |
Why?
|
Aging | 1 | 2004 | 857 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 1997 | 6 | 0.040 |
Why?
|
Comorbidity | 1 | 2019 | 531 | 0.040 |
Why?
|
Pilot Projects | 1 | 2018 | 437 | 0.040 |
Why?
|
Cyclic GMP | 1 | 1996 | 8 | 0.040 |
Why?
|
Injections, Epidural | 1 | 1996 | 9 | 0.040 |
Why?
|
Potassium Chloride | 2 | 1996 | 4 | 0.040 |
Why?
|
Life Style | 1 | 2019 | 372 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 774 | 0.040 |
Why?
|
Parasympathetic Nervous System | 1 | 1996 | 2 | 0.040 |
Why?
|
Nausea | 1 | 1996 | 49 | 0.040 |
Why?
|
Sympathomimetics | 1 | 1996 | 4 | 0.040 |
Why?
|
Pain Threshold | 2 | 2008 | 90 | 0.040 |
Why?
|
Narcotic Antagonists | 2 | 2012 | 25 | 0.040 |
Why?
|
Vasoconstriction | 2 | 1996 | 42 | 0.040 |
Why?
|
Aged | 2 | 2019 | 9256 | 0.030 |
Why?
|
Computers | 1 | 1995 | 16 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 1996 | 63 | 0.030 |
Why?
|
Sympathetic Nervous System | 1 | 1995 | 30 | 0.030 |
Why?
|
Epidermis | 1 | 2015 | 22 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2015 | 90 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 1997 | 700 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2016 | 134 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2015 | 71 | 0.030 |
Why?
|
Treatment Failure | 1 | 2015 | 142 | 0.030 |
Why?
|
Blotting, Western | 1 | 2015 | 265 | 0.030 |
Why?
|
N-Methylaspartate | 1 | 1994 | 6 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2015 | 480 | 0.030 |
Why?
|
DNA | 1 | 2015 | 207 | 0.030 |
Why?
|
Receptors, Cholinergic | 1 | 1993 | 21 | 0.030 |
Why?
|
Risk Assessment | 1 | 2019 | 1285 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2015 | 779 | 0.030 |
Why?
|
Arginine Vasopressin | 1 | 1992 | 1 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2015 | 430 | 0.030 |
Why?
|
Hypotension | 1 | 1993 | 45 | 0.030 |
Why?
|
Shock | 1 | 1992 | 28 | 0.030 |
Why?
|
Receptors, Opioid, mu | 1 | 2012 | 21 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 1992 | 90 | 0.030 |
Why?
|
Fetus | 1 | 1992 | 75 | 0.030 |
Why?
|
Blood Pressure | 1 | 1996 | 861 | 0.030 |
Why?
|
Carbachol | 1 | 1991 | 6 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2018 | 2886 | 0.020 |
Why?
|
Risk Factors | 1 | 2019 | 3520 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2010 | 46 | 0.020 |
Why?
|
Microdialysis | 2 | 2001 | 12 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2015 | 2027 | 0.020 |
Why?
|
Hypogastric Plexus | 1 | 2008 | 5 | 0.020 |
Why?
|
Electrophysiology | 1 | 2008 | 38 | 0.020 |
Why?
|
United States | 1 | 2016 | 3588 | 0.020 |
Why?
|
Pyrazoles | 1 | 2006 | 51 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 169 | 0.020 |
Why?
|
Pirenzepine | 2 | 1995 | 2 | 0.020 |
Why?
|
Erythrocyte Count | 1 | 2004 | 5 | 0.020 |
Why?
|
Spinal Cord Compression | 1 | 2004 | 5 | 0.020 |
Why?
|
Hematocrit | 1 | 2004 | 20 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2004 | 54 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 498 | 0.020 |
Why?
|
Dogs | 1 | 2004 | 114 | 0.020 |
Why?
|
Bupivacaine | 1 | 2004 | 48 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2004 | 75 | 0.010 |
Why?
|
Body Weight | 1 | 2004 | 289 | 0.010 |
Why?
|
Adolescent | 1 | 2010 | 3184 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2001 | 21 | 0.010 |
Why?
|
Fluorobenzenes | 1 | 2001 | 22 | 0.010 |
Why?
|
Fluorine Radioisotopes | 1 | 2001 | 16 | 0.010 |
Why?
|
Inflammation | 1 | 2004 | 501 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2001 | 133 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 1999 | 13 | 0.010 |
Why?
|
Adrenergic Agents | 1 | 1997 | 3 | 0.010 |
Why?
|
Algorithms | 1 | 1999 | 456 | 0.010 |
Why?
|
Femoral Nerve | 1 | 1996 | 6 | 0.010 |
Why?
|
Guanylate Cyclase | 1 | 1996 | 4 | 0.010 |
Why?
|
Microchemistry | 1 | 1996 | 4 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1996 | 16 | 0.010 |
Why?
|
Arginine | 1 | 1996 | 15 | 0.010 |
Why?
|
Dialysis | 1 | 1996 | 3 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 42 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1996 | 53 | 0.010 |
Why?
|
Fentanyl | 1 | 1996 | 28 | 0.010 |
Why?
|
Vasodilation | 1 | 1996 | 92 | 0.010 |
Why?
|
Dopamine | 1 | 1996 | 42 | 0.010 |
Why?
|
Arteries | 1 | 1996 | 61 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 147 | 0.010 |
Why?
|
Respiration | 1 | 1995 | 23 | 0.010 |
Why?
|
Drug Combinations | 1 | 1995 | 83 | 0.010 |
Why?
|
Muscle Relaxation | 1 | 1994 | 5 | 0.010 |
Why?
|
Amino Acid Oxidoreductases | 1 | 1994 | 5 | 0.010 |
Why?
|
Aorta | 1 | 1994 | 105 | 0.010 |
Why?
|
Medetomidine | 1 | 1993 | 2 | 0.010 |
Why?
|
Basilar Artery | 1 | 1992 | 7 | 0.010 |
Why?
|
Catecholamines | 1 | 1992 | 15 | 0.010 |
Why?
|
Femoral Artery | 1 | 1992 | 39 | 0.010 |
Why?
|